China Taiping Insurance Holdings Co (HKSE:00966) Research & Development: HK$0 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:00966 China Taiping Insurance Holdings Co Ltd HKSE:00966
76 GF Score
Price HK$18.39
GF Value HK$13.34
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is China Taiping Insurance Holdings Co Research & Development?

China Taiping Insurance Holdings Co HKSE:00966 -0.59% 76 Research & Development is HK$0 Mil as of Dec. 2025. GuruFocus rates HKSE:00966 with a GF Score™ of 76/100 and a GF Value™ of HK$13.34 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. China Taiping Insurance Holdings Co's Research & Development for the six months ended in Dec. 2025 was HK$0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0 Mil.

China Taiping Insurance Holdings Co  (HKSE:00966) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

China Taiping Insurance Holdings Co Research & Development Related Terms

China Taiping Insurance Holdings Co Research & Development Historical Data

* Premium members only.

The historical data trend for China Taiping Insurance Holdings Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Taiping Insurance Holdings Co Research & Development Chart

China Taiping Insurance Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

China Taiping Insurance Holdings Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HKSE:00966
76GF Score
China Taiping Insurance Holdings Co Ltd HKSE:00966
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Taiping Insurance Holdings Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of HK$0 Mil mean?
China Taiping Insurance Holdings Co (HKSE:00966) has a Research & Development of HK$0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on China Taiping Insurance Holdings Co and its competitors.
Is China Taiping Insurance Holdings Co's Research & Development too high?
China Taiping Insurance Holdings Co's current Research & Development is HK$0 Mil. Overall, China Taiping Insurance Holdings Co has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does China Taiping Insurance Holdings Co's Research & Development compare to AFL and MET?
China Taiping Insurance Holdings Co's Research & Development of HK$0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on China Taiping Insurance Holdings Co and its competitors. China Taiping Insurance Holdings Co's current Research & Development is HK$0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Taiping Insurance Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, China Taiping Insurance Holdings Co (HKSE:00966) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$13.34, compared to a current price of HK$18.39 — trading 37.9% above its estimated fair value. The current Research & Development is HK$0 Mil. China Taiping Insurance Holdings Co's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For China Taiping Insurance Holdings Co (HKSE:00966), the current Research & Development is HK$0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Taiping Insurance Holdings Co (HKSE:00966) Overvalued in 2026?

Based on GuruFocus' analysis, China Taiping Insurance Holdings Co stock appears to be overvalued. The current stock price of HK$18.39 is trading 37.9% above its estimated GF Value™ of HK$13.34. GuruFocus considers China Taiping Insurance Holdings Co to be Significantly Overvalued.

Key valuation signals for HKSE:00966:

  • Research & Development: HK$0 Mil
  • GF Value™: HK$13.34 vs. price of HK$18.39 (37.9% above fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the HKSE:00966 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

China Taiping Insurance Holdings Co Business Description

Other Exchanges CTIHY:USAHIUC:Germany
Address 18 King Wah Road, 25th Floor, China Taiping Finance Centre, North Point, Hong Kong, HKG
China Taiping Insurance Holdings Co Ltd is a holding company that, through its subsidiaries, sells insurance products and offers a variety of investment management services. The company sells life, property and casualty, reinsurance, and pension insurance products. The firm also operates asset management and real estate management services. The majority of China Taiping Insurance's income is derived from life insurance, with the People's Republic of China contributing a portion of the company's revenue. The company comprises business segments: the life insurance business, PRC property and casualty insurance business, Overseas property and casualty insurance business, reinsurance business, and Others. The majority of revenue is generated from the life insurance business.
76GF Score

Get the complete analysis for HKSE:00966

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$18.39
Price
HK$13.34
GF Value